# Bioequivalence and Drug - Drug Interaction Study of Metformin/Gliclazide in Healthy Participants

> **NCT03467945** · PHASE1 · COMPLETED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 40 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Metformin/Gliclazide Fixed Combination
- **DRUG:** Metformin
- **DRUG:** Gliclazide

## Key facts

- **NCT ID:** NCT03467945
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-16
- **Primary completion:** 2018-04-29
- **Final completion:** 2018-04-29
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03467945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03467945, "Bioequivalence and Drug - Drug Interaction Study of Metformin/Gliclazide in Healthy Participants". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03467945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*